Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study - Concepedia

Concepedia

Publication | Open Access

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study

DOI Full Paper Access

63

Citations

15

References

2018

Year

Eric Van Cutsem, Takayuki Yoshino, Heinz‐Josef Lenz, Sara Lonardi, Alfredo Falcone, M. Luisa Limon, Mark Saunders, Alberto Sobrero, Y.S. Park, Reyes Ferreiro,

Annals of Oncology

References

	Year	Citations

Page 1